1/13
09:52 am
ilmn
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery [Yahoo! Finance]
Low
Report
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery [Yahoo! Finance]
1/13
09:15 am
ilmn
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
Low
Report
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
1/13
09:00 am
ilmn
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Low
Report
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
1/12
04:07 pm
ilmn
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
Low
Report
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
1/8
05:22 pm
ilmn
Illumina Appoints Dr. Eric Green as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Illumina Appoints Dr. Eric Green as Chief Medical Officer [Yahoo! Finance]
1/8
04:30 pm
ilmn
Illumina Appoints Dr. Eric Green as Chief Medical Officer
Medium
Report
Illumina Appoints Dr. Eric Green as Chief Medical Officer
1/7
01:18 pm
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at TD Cowen from $115.00 to $140.00. They now have a "hold" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at TD Cowen from $115.00 to $140.00. They now have a "hold" rating on the stock.
1/7
10:58 am
ilmn
Illumina (NASDAQ:ILMN) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold" rating reaffirmed by analysts at Cowen Inc.
1/6
09:41 am
ilmn
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis [Yahoo! Finance]
Low
Report
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis [Yahoo! Finance]
1/6
09:15 am
ilmn
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Medium
Report
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
1/5
10:58 am
ilmn
Illumina (NASDAQ:ILMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Illumina (NASDAQ:ILMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/5
10:16 am
ilmn
Illumina (NASDAQ:ILMN) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Illumina (NASDAQ:ILMN) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/3
05:42 am
ilmn
Illumina (NASDAQ:ILMN) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Illumina (NASDAQ:ILMN) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
1/3
01:06 am
ilmn
Medium
Report
12/22
11:03 am
ilmn
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
12/22
08:02 am
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $112.00 to $130.00. They now have a "hold" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $112.00 to $130.00. They now have a "hold" rating on the stock.
12/17
04:35 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/16
04:05 pm
ilmn
Illumina To Webcast Upcoming Investor Conference
Low
Report
Illumina To Webcast Upcoming Investor Conference
12/15
02:24 pm
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.
12/15
06:04 am
ilmn
Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
12/11
04:19 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
09:39 am
ilmn
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually [Yahoo! Finance]
Low
Report
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually [Yahoo! Finance]
12/11
09:15 am
ilmn
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Low
Report
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
12/5
04:22 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/4
07:18 am
ilmn
Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.